Close
CDMO Safety Testing 2026
Novotech

Press Releases

Quotient Sciences Announces Major Investment in Sterile Fill/Finish Capacity in Response to Increasing Industry Demand

Quotient Sciences, the drug development and manufacturing accelerator, announced that it has made a major investment in the sterile fill/finish capabilities at its Alnwick, UK facility. This investment will increase the current capacity of the Annex 1 compliant facility...

Vetter Further Invests โ‚ฌ230M in New Production Building

Vetter, a global CDMO, is making additional investments as part of its long-lead goals for continued expansion and to support customer needs.ย The company is investing โ‚ฌ230 million in its new production building, which is currently under construction at its...

Lonza to enhance commercial antibody-drug conjugate supply capacity

Lonza is planning to build a commercial-scale aseptic current good manufacturing practice (cGMP) filling line at its site in Stein, Switzerland. The new filling line will facilitate the aseptic filling of highly-potent antibody drug conjugates (ADCs) and lyophilisation under...

Turkish Cargo Chosen as The Best Air Cargo Brand of Europe

Turkish Cargo, successful brand of Turkish Airlines, is chosen as the best air cargo brand of Europe and received โ€œBest Cargo Airline โ€“ Europeโ€ award during the Air Cargo News Awards 2023 which was organized for the 39th time...

Vetter looks ahead to further expansions to meet supply chain demand

Committed to sustainable growth and long-term planning Dedicated to making investments to support increased customer demand Maintain efficiency and quality in development and manufacturing processes Ravensburg, Germany, October 17, 2023: Vetter, a leading global Contract Development and Manufacturing Organization...

Cellares Announces Expanded Agreement with BMS to Include Second CAR-T Program in Cellares Technology Adoption Partnership Program

Cellares, the first Integrated Development and Manufacturing Organization (IDMO) dedicated to clinical and industrial-scale cell therapy manufacturing, announced that global biopharmaceutical company and cell therapy leader Bristol Myers Squibbย  will enter a second proof-of-concept tech transfer process for the...

Sygnature Discovery collaborates with Axol Bioscience to utilize human iPSC-derived microglial cells in high-content imaging drug discovery screening workflows

Sygnature Discovery, a world-leading integrated drug discovery provider and non-clinical solutions provider, has announced a scientific collaboration with human induced pluripotent stem cell (iPSC) experts, Axol Bioscience. The collaboration aims to explore the incorporation of human iPSC-derived microglia into high-content...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate ยป